List of medications
Regulation respecting the List of medications covered by the basic prescription drug insurance plan (CQLR, chapter A-29.01, r. 3)
The List of medications constitutes a regulatory list of the medications covered by Québec’s basic prescription drug insurance plan. See list update schedule.
For previous versions of the list, see the register below. The "Related legal document" links point to the minister’s orders and RAMQ notices pertaining to the list.
Please note that under the seventh paragraph of section 60 and section 60.1 of the Act respecting prescription drug insurance (CQLR, chapter A-29.01), publication on this website of a regulation respecting the List of medications and of the Related legal documents imparts authentic value to them.
Notices of end of coverage
No notice of end of coverage
Notices of exclusion
No notice of exclusion
Notices of replacement
- Notice of alternative medication authorization, November 13, 2023 – VictozaTM liraglutide (rupture) and TrulicityTM dulaglutide (rupture) replace Semaglutide (Ozempic)
- Notice of alternative medication authorization, November 6, 2023 – Carbamazepine replaces:
- Taro-Carbamazepine
- Tegretol
- Notice of alternative medication authorization, November 1, 2023 – Vigabatrin replaces Sabril
- Notice of alternative medication authorization, October 18, 2023 – Epinephrine hydrochloride replaces Epinephrine
- Notice of alternative medication authorization, September 13, 2023 – Valganciclovir hydrochloride replaces Valcyte
- Notice of alternative medication authorization, October 17, 2023 – Nutritional formula – Monogen Nutricia replaces Portagen
- Notice of alternative medication authorization, October 13, 2023 – Niraparib tosylate replaces Zejula
- Notice of alternative medication authorization, October 16, 2023 – Prazosin hydrochloride replaces Teva-Prazosin
- Notice of alternative medication authorization, September 25, 2023 – Chlordiazepoxide hydrochloride replaces Chlordiazepoxide
- Notice of alternative medication authorization, September 25, 2023 – Diazepam replaces:
- Diastat 1 mL (5 mg)
- Diastat 2 mL (10 mg)
- Diastat 3 mL (15 mg)
- Notice of alternative medication authorization, September 7, 2023 – Valganciclovir hydrochloride replaces Valcyte
- Notice of alternative medication authorization, August 21, 2023 – Atropine sulfate replaces:
- Atropine
- Isopto Atropine
- Notice of alternative medication authorization, August 31, 2023 – Folic acid replaces:
- Jamp-Folic Acid
- M-Folique 1 mg
- Notice of alternative medication authorization, June 19, 2023 – Indomethacin replaces Sandoz Indomethacin
- Notice of alternative medication authorization, June 6, 2023 – Medroxyprogesterone acetate replaces:
- Apo-Medroxy
- Novo-Medrone
- Notice of alternative medication authorization, July 17, 2023 – Megestrol acetate replaces Megestrol acetate
- Notice of alternative medication authorization, July 6, 2023 – Metronidazole replaces diphenhydramine hydrochloride
- Notice of alternative medication authorization, November 13, 2023 – VictozaTM liraglutide (rupture) and TrulicityTM dulaglutide (rupture) replace Semaglutide (Ozempic)
- Notice of alternative medication authorization, November 6, 2023 – Carbamazepine replaces:
- Taro-Carbamazepine
- Tegretol
- Notice of alternative medication authorization, November 1, 2023 – Vigabatrin replaces Sabril
- Notice of alternative medication authorization, October 18, 2023 – Epinephrine hydrochloride replaces Epinephrine
- Notice of alternative medication authorization, September 13, 2023 – Valganciclovir hydrochloride replaces Valcyte
- Notice of alternative medication authorization, October 17, 2023 – Nutritional formula – Monogen Nutricia replaces Portagen
- Notice of alternative medication authorization, October 13, 2023 – Niraparib tosylate replaces Zejula
- Notice of alternative medication authorization, October 16, 2023 – Prazosin hydrochloride replaces Teva-Prazosin
- Notice of alternative medication authorization, September 25, 2023 – Chlordiazepoxide hydrochloride replaces Chlordiazepoxide
- Notice of alternative medication authorization, September 25, 2023 – Diazepam replaces:
- Diastat 1 mL (5 mg)
- Diastat 2 mL (10 mg)
- Diastat 3 mL (15 mg)
- Notice of alternative medication authorization, September 7, 2023 – Valganciclovir hydrochloride replaces Valcyte
- Notice of alternative medication authorization, August 21, 2023 – Atropine sulfate replaces:
- Atropine
- Isopto Atropine
- Notice of alternative medication authorization, August 31, 2023 – Folic acid replaces:
- Jamp-Folic Acid
- M-Folique 1 mg
- Notice of alternative medication authorization, June 19, 2023 – Indomethacin replaces Sandoz Indomethacin
- Notice of alternative medication authorization, June 6, 2023 – Medroxyprogesterone acetate replaces:
- Apo-Medroxy
- Novo-Medrone
- Notice of alternative medication authorization, July 17, 2023 – Megestrol acetate replaces Megestrol acetate
- Notice of alternative medication authorization, July 6, 2023 – Metronidazole replaces diphenhydramine hydrochloride
- Notice of alternative medication authorization, June 6, 2023
- Medroxyprogesterone acetate (99114209) remplaces:
- Apo-Medroxy
- Novo-Medrone
- Medrozyprogesterone acetate (99114210) replaces Apo-Medroxy
- Medroxyprogesterone acetate (99114209) remplaces:
- Notice of alternative medication authorization, June 14, 2023 – Vigabatrin replaces Sabril
- Notice of alternative medication authorization, June 16, 2023 – Metronidazole replaces Nidagel
- Notice of alternative medication authorization, June 6, 2023 – Medroxyprogesterone acetate replaces:
- Apo-Medroxy
- Novo-Medrone
- Notice of alternative medication authorization, June 2, 2023 – Mexiletine hydrochloride replaces Teva-Mexiletine
- Notice of alternative medication authorization, June 1, 2023 – Paraffin/Mineral oil replaces Lacrilube
- Notice of alternative medication authorization, June 1, 2023 – Progesterone replaces ACT Progesteron Injection
- Notice of alternative medication authorization, May 31, 2023:
- Prazosin hydrochloride, capsules, 0.5 mg replaces Teva-Prazosin, tablets, 1 mg
- Prazosin hydrochloride, tablets and capsules, 1 mg replaces Teva-Prazosin, tablets, 1 mg
- Prazosin hydrochloride, tablets and capsules, 2 mg replaces Teva-Prazosin, tablets, 2 mg
- Prazosin hydrochloride, tablets and capsules, 5 mg replaces Teva-Prazosin, tablets, 5 mg
- Notice of alternative medication authorization, May 10, 2023:
- Prazosin hydrochloride, tablets and capsules, 1 mg replaces Teva-Prazosin, tablets, 1 mg
- Prazosin hydrochloride, tablets and capsules, 2 mg replaces Teva-Prazosin, tablets, 2 mg
- Prazosin hydrochloride, tablets and capsules, 5 mg replaces Teva-Prazosin, tablets, 5 mg
- Notice of alternative medication authorization, May 5, 2023 – Hydroxyzine hydrochloride replaces:
- Hydroxyzine
- Teva-Hydroxyzin
- Notice of alternative medication authorization, April 28, 2023 – Cyclopentolate hydrochloride replaces:
- Cyclogil
- Odan-Cyclopentolate
- Notice of alternative medication authorization, April 28, 2023 – Atropine sulfate replaces:
- Atropine
- Isopto Atropine
- Notice of alternative medication authorization, April 20, 2023 – Clindamycin phosphate replaces Taro-Clindamycin
- Notice of alternative medication authorization, April 13, 2023 – Prednisolone acetate replaces:
- Ratio-Prednisolone
- Sandoz Prednisolone
- Notice of alternative medication authorization, April 13, 2023 – Trifluoperazine hydrochloride replaces Trifluoperazine
- Notice of alternative medication authorization, March 30 2023 – Quinapril hydrochloride 5 mg, 10 mg, 20 mg et 40 mg replace:
- Accupril
- Apo-Quinapril
- pms-Quinapril
- Notice of alternative medication authorization, March 14, 2023 – Thiamine hydrochloride replaces Thiamiject
- Notice of alternative medication authorization, March 9, 2023 – Minoxidil replaces Loniten
- Notice of alternative medication authorization, December 28, 2022 – Propranolol hydrochloride replaces Teva-Propranolol
- Notice of alternative medication authorization, February 28, 2023 – Hydroxyzine hydrochloride rempaces:
- Hydroxyzine
- Novo-Hydroxyzin
- Notice of alternative medication authorization, February 27, 2023 – Ergocalciferol replaces Jamp-D2-Dol
- Notice of alternative medication authorization, February 16, 2023 – Imipenem/Cilastatin sodium replaces Taro-Imipenem-Cilastatin
- Notice of alternative medication authorization, February 16, 2023:
- Prazosin hydrochloride 1 mg remplace Teva-Prazosin 1 mg
- Prazosin hydrochloride 2 mg remplace Teva-Prazosin 2 mg
- Prazosin hydrochloride 5 mg remplace Teva-Prazosin 5 mg
- Notice of alternative medication authorization, January 30, 2023 – Folic acid replaces:
- Euro-Folic
- Jamp-Folic Acid
- Notice of alternative medication authorization, January 5, 2023 – Furosemide replaces Lasix Special
- Notice of alternative medication authorization, January 4, 2023 – Gentamicin sulfate replaces Gentamicin Injection
- Notice of alternative medication authorization, December 6, 2022 – Nifedipine replaces Nifedipine
- Notice of alternative medication authorization, November 7, 2022 – Amoxicillin replaces:
- Amoxicillin
- Apo-Amoxi
- Auro-Amoxicillin
- Novamoxin
- Novamoxin-250
- pms-Amoxicillin
- Pro-Amox-250
- Notice of alternative medication authorization, December 28, 2022 – Rifampin 150 mg et 300 mg replace:
- Rofact 150
- Rofact 300
- Notice of alternative medication authorization, December 16, 2022 – Codeine phosphate, 25 mg/5 ml, Syr. replaces Codeine
- Notice of alternative medication authorization, December 16, 2022 – Codeine phosphate, 30 mg, Caps. replaces:
- Codeine
- Teva-Codeine
- Notice of alternative medication authorization, December 13, 2022 – Propranolol hydrochloride replaces Teva-Propranolol
- Notice of alternative medication authorization, December 6, 2022 – Heparine sodium replaces Heparin sodium injection, USP
- Notice of alternative medication authorization, December 6, 2022 – Heparine sodium replaces Heparin sodium injection, USP
- Notice of alternative medication authorization, December 6, 2022 – Nifedipine replaces Nifedipine
- Notice of alternative medication authorization, December 2, 2022 – Acetylcysteine solution replaces Acetylcysteine
- Notice of alternative medication authorization, December 1, 2022 – Minoxidil replaces Loniten
- Notice of alternative medication authorization, November 24, 2022 – Amoxicillin/Potassium clavulanate replaces Clavulin-400
- Notice of alternative medication authorization, October 14, 2022 – Haloperidol replaces Teva-Haloperidol
- Notice of alternative medication authorization, November 15, 2022 – Spironolactone replaces:
- Jamp Spironolactone
- Mint-Spironolactone
- Teva-Spironolactone
- Notice of alternative medication authorization, November 7, 2022 – Quinine sulfate replaces:
- Jamp-Quinine
- Novo-Quinine
- Pro-Quinine-200
- Quinine-Odan (Caps.)
- Notice of alternative medication authorization, November 3, 2022 – Atropine sulfate replaces:
- Atropine
- Isopto Atropine
- Notice of alternative medication authorization, November 16, 2022 – Diphenhydramine (chlorhydrate de) replaces Diphenhydramine (chlorhydrate de)
- Notice of alternative medication authorization, October 31, 2022 – Spironolactone replaces:
- Jamp Spironolactone
- Mint-Spironolactone
- Teva-Spironolactone
- Notice of alternative medication authorization, October 28, 2022 – Ibuprofene replaces Europrofen
- Notice of alternative medication authorization, October 24, 2022 – Estradiol-17B replaces Estrogel
- Notice of alternative medication authorization, October 24, 2022 – Prochlorperazine replaces Sandoz Prochloperazine
- Notice of alternative medication authorization, September 2, 2022 – Sulfasalazine replaces Pms-Sulfasalazine-E.C
- Notice of alternative medication authorization, October 14, 2022 – Haloperidol replaces Teva-Haloperidol
- Notice of alternative medication authorization, October 17, 2022 – Acetaminophene replace:
- Jamp-Acetaminophene
- Pediatrix
- Notice of alternative medication authorization, October 13, 2022 – Betamethasone valerate replaces Betaderm Taro
- Notice of alternative medication authorization, October 7, 2022 – Oxycodone hydrochloride 10 mg and 20 mg replace Supeudol Sandoz
- Notice of alternative medication authorization, October 5, 2022 – Amoxicillin/Potassium clavulanate replaces GSK Clavulin-400
- Notice of alternative medication authorization, September 16, 2022 – Penicillin G Sodium replaces Penicillin G
- Notice of alternative medication authorization, August 22, 2022 – Heparin sodium replaces Heparin sodium injection, USP
- Notice of alternative medication authorization, August 18, 2022 – Electrolyte replacement/dextrose replace:
- Gastrolyte
- Jamp Rehydralyte
- Notice of alternative medication authorization, August 16, 2022 – Trifluoperazine hydrochloride replaces Trifluoperazine
- Notice of alternative medication authorization, August 16, 2022 – Trifluoperazine hydrochloride (5 mg – Caps.), Trifluoperazine hydrochloride (10 mg – Caps.), and Trifluoperazine hydrochloride (20 mg – Caps.) replace:
- Trifluoperazine hydrochloride (5 mg – Tab.)
- Trifluoperazine hydrochloride (10 mg – Tab.)
- Trifluoperazine hydrochloride (20 mg – Tab.)
- Notice of alternative medication authorization, August 8, 2022 – Hydroxyzine hydrochloride replaces:
- Hydroxyrine
- Novo-Hydroxyzin
- Notice of alternative medication authorization, August 8, 2022 – Acetaminophen (160 mg/5 ml – Liq.), and Acetaminophen (160 mg/5 ml – Liq.) replace:
- Acetaminophen
- Jamp-Acetaminophen
- PDP-Acetaminophen solution
- Notice of alternative medication authorization, July 29, 2022 – Diphenhydramine hydrochloride replaces Diphenhydramine hydrochloride
- Notice of alternative medication authorization, July 18, 2022 – Nutritional formula – infants and children (Althéra UK) and Nutritional formula – infants and children (Alfamino UK) replace:
- Alimentum
- Nutramigen A+
- Pregestimil A+
- Nutramigen A+ LGG
- Notice of alternative medication authorization, July 11, 2022 – Tocilizumab (162 mg/0.9 ml (4 ml)), Tocilizumab (162 mg/0.9 ml (10 ml)) and Tocilizumab (162 mg/0.9 ml (20 ml)) replace:
- Actemra (162 mg/0.9 ml) – S.C. Inj. Sol (syr)
- Actemra (162 mg/0.9 ml) – S.C. Inj. Sol (pen)
- Notice of alternative medication authorization, June 27, 2022 – Nutritional formula – infants and children (Similac Alimentum US 946 ml) replaces:
- Alimentum
- Nutramigen A+
- Pregestimil A+
- Nutramigen A+ LGG
- Notice of alternative medication authorization, June 17, 2022 – Diazapam replaces:
- Diastat 1 ml (5 mg)
- Diastat 2 ml (10 mg)
- Notice of alternative medication authorization, June 17, 2022 – Imipenem/Cilastatin sodium replaces Primaxin
- Notice of alternative medication authorization, June 17, 2022 – Hydrocortisone replaces Cortef
- Notice of alternative medication authorization, June 15, 2022 – Minoxidil replaces Loniten
- Notice of alternative medication authorization, June 14, 2022 – Nutritional formula – infants and children (Nestlé Gerber Good Start Extensive HS – imported) remplaces:
- Alimentum
- Nutramigen A+
- Pregestimil A+
- Nutramigen A+ LGG
- Notice of alternative medication authorization, June 10, 2022 – Insulin lispro replaces Admelog SanofiAven
- Notice of alternative medication authorization, May 31, 2022 – Nutritional formula – infants and children (Nutramigen A+ concentrated – imported) rempaces:
- Alimentum
- Nutramigen A+
- Pregestimil A+
- Nutramigen A+ LGG
- Notice of alternative medication authorization, May 26, 2022 – Terbutatine sulfate replaces Bricanyl Turbuhaler
- Notice of alternative medication authorization, May 18, 2022 – Octreotide acetate (99113996) replaces Sandostatin
- Notice of alternative medication authorization, May 17, 2022 – Minoxidil (99113991) replaces Loniten
- Notice of alternative medication authorization, May 17, 2022 – Minoxidil (99113992) replaces Loniten
- Notice of alternative medication authorization, May 16, 2022 – Fludrocortisone acetate replaces Florinef
- Notice of alternative medication authorization, May 16, 2022 – Fludrocortisone acetate (99113993) replaces Florinef
- Notice of alternative medication authorization, May 16, 2022 – Fludrocortisone acetate (99113994) replaces Florinef
- Notice of alternative medication authorization, May 4, 2022 – Octreotide acetate (99113995) replaces Sandostatin
- Notice of alternative medication authorization, May 1, 2022 – Nutritional formula - casein Hydrolysate(infants and children) replaces:
- Alimentum
- NutramigenA+
- Presgestimil A+
- Nutramigen A+ LGG
- Notice of alternative medication authorization, March 30, 2022 – Sodium phosphate monobasic / Sodium phosphate dibasic replaces Lax-A NEMA
- Notice of alternative medication authorization, January 21, 2022 – carbamazepine (99113958) replaces:
- Taro-Carbamazepine
- Tegretol
- Notice of alternative medication authorization, January 21, 2022 – carbamazepine (99113955) replaces:
- Taro-Carbamazepine
- Tegretol
- Notice of alternative medication authorization, January 21, 2022 – carbamazepine (99113954) replaces:
- Taro-Carbamazepine
- Tegretol
- Notice of alternative medication autorization, January 21, 2022 – hydrocortisone replaces Sandoz Hydrocortisone
- Notice of alternative medication authorization, December 16, 2021 – Medroxyprogesterone acetate (99113945) replaces Apo-Medroxy
- Notice of alternative medication authorization, December 7, 2021 – Progesterone replaces ACT Progesteron Injection
- Notice of alternative medication authorization, December 2, 2021 – Medroxyprogesterone acetate (99113940) replaces:
- Apo-Medroxy
- Novo-Medrone
- Notice of alternative medication authorization, December 2, 2021 – Medroxyprogesterone acetate (99113939) replaces:
- Apo-Medroxy
- Novo-Medrone
- Notice of alternative medication authorization, December 2, 2021 – Medroxyprogesterone acetate (99113938) replaces:
- Apo-Medroxy
- Novo-Medrone
- Provera
- Notice of alternative medication authorization, December 2, 2021 – Sulfasalazine replaces pms-Sulfasalazine
- Notice of alternative medication authorization, November 30, 2021 – Famatidine replaces Novo-Famotidine
- Notice of alternative medication authorization, November 25, 2021 – Medroxyprogesterone acetate (99113947) replaces
- Apo-Medroxy
- Novo-Medroxy
- Notice of alternative medication authorization, November 25, 2021 – Medroxyprogesterone acetate (99113937) replaces :
- Apo-Medroxy
- Novo-Medrone
- Notice of alternative medication authorization, November 25, 2021 – Medroxyprogestérone acetate (99113933) replaces:
- Apo-Medroxy
- Novo-Medrone
- Notice of alternative medication authorization, August 20, 2021 – Estrone replaces Estragyn vaginal cream
- Notice of alternative medication authorization, July 8, 2021 – Metroxyprogesterone acetate replaces Depo-Provera
- Notice of alternative medication authorization, May 28, 2021 – Atropine sulfate 5 ml replaces:
- Atropine
- Isopto Atropine
- Notice of alternative medication authorization, May 28, 2021 – Atropine sulfate 0.5 ml replaces:
- Atropine
- Isopto Atropine
- Notice of alternative medication authorization, May 20, 2021 – Phenelzine sulfate replaces Phenelzine sulfate
- Notice of alternative medication authorization, May 19, 2021 – Trifluoperazine hydrochlorhide replaces Trifluoperazine
- Notice of alternative medication authorization, May 18, 2021 – Sodium chloride replaces Nebusal 7%
- Notice of alternative medication authorization, May 11, 2021 – Bacitracine replaces Bacitracin
- Notice of alternative medication authorization, April 13, 2021 – Pindolol replaces:
- Apo-Pindol
- Novo-Pindol
- Visken
- Notice of alternative medication authorization, April 6, 2021 – Pindolol replaces:
- Apo-Pindol
- Novo-Pindol
- Visken
- Notice of alternative medication authorization, April 6, 2021 – Pindolol replaces:
- Apo-Pindol
- Novo-Pindol
- Visken
- Notice of alternative medication authorization, March 12, 2021 – Sodium phosphate monobasic and dibasic replaces:
- Fleet
- Lax-A NEMA
- Notice of alternative medication authorization, February 18, 2021 – Ibuprofen replaces Europrofen
- Notice of alternative medication authorization, February 18, 2021 – Metoprolol tartrate replaces:
- Lopresor SR
- Metoprolol SR
- Sandoz Metoprolol SR
- Notice of alternative medication authorization, February 9, 2021 – Trifluoperazine hydrochloride replaces Trifluoperazine
- Notice of alternative medication authorization, February 2, 2021 – Trifluoperazine hydrochloride replaces Trifluoperazine
- Notice of alternative medication authorization, January 15, 2021 – Hydromorphone hydrochloride replaces pms-Hydromorphone
- Notice of alternative medication authorization, January 8, 2021 – Nicoumalone replaces Sintrom
- Notice of alternative medication authorization, December 8, 2020 – Acyclovir sodium replaces:
- Acyclovir Sodique
- Acyclovir sodique injectable
- Notice of alternative medication authorization, October 27, 2020 – Spironolactone replaces:
- Mint-Spironolactone
- Teva-Spironolactone
- Notice of alternative medication authorization, October 26, 2020 – fluvastatine sodium replaces:
- Sandoz Fluvastatin
- Teva Fluvastatin
- Notice of alternative medication authorization, October 26, 2020 – Fluvastatine sodium replaces Teva Fluvastatin
- Notice of alternative medication authorization, October 19, 2020 – Manerix replaces moclobemid
- Notice of alternative medication authorization, October 19, 2020 – Manerix replaces moclobemid
- Notice of alternative medication authorization, September 25, 2020 – Palbociclib replaces Ibrance
- Notice of alternative medication authorization, September 25, 2020 – Palbociclib replaces Ibrance
- Notice of alternative medication authorization, September 25, 2020 – Palbociclib replaces Ibrance
- Notice of alternative medication authorization, September 21, 2020 – Buprenorphine replaces Sublocade
- Notice of alternative medication authorization, September 21, 2020 – Buprenorphine replaces Sublocade
- Notice of alternative medication authorization, July 16, 2020 – Propylthiouracil replaces Propyl-Thyracil
- Notice of alternative medication authorization, July 6, 2020 – Timolol maleate replaces:
- Apo-Timop
- Jamp-Timolol
- pms-Timolol
- Sandoz Timolol
- Timoptic
- Notice of alternative medication authorization, July 6, 2020 – Timolol maleate replaces:
- Apo-Timop
- Jamp-Timolol
- pms-Timolol
- Sandoz Timolol
- Timoptic
- Notice of alternative medication authorization, June 12, 2020 – Erythromycin replaces Erythro-Base
- Notice of alternative medication authorization, June 11, 2020 – trifluoperazine hydrochloride replace Trifluoperazine
- Notice of alternative medication authorization, June 2, 2020 – nystatine replaces:
- Nyaderm
- ratio-Nystatin
- Notice of alternative medication authorization, May 22, 2020 – Salbutamol replaces:
- Airomir
- Apo-Salvent sans CFC
- Novo-Salbutamol HFA
- Salbutamol HFA
- Ventolin HFA
- Notice of alternative medication authorization, May 20, 2020 – Temozolomide replaces:
- ACT Temozolomide
- Taro-Temozolomide
- Temodal
- Notice of alternative medication authorization, May 6, 2020 – phenelzine sulfate replaces Nardil
- Notice of alternative medication authorization, May 6, 2020 – Diazepam replaces Diastat
- Notice of alternative medication authorization, April 30, 2020 – Temozolomide replaces:
- Act Temozolomide
- Taro-Temozolomide
- Temodal
- Notice of alternative medication authorization, April 27, 2020 – Mexiletine replaces Novo-Mexiletine
- Notice of alternative medication authorization, April 24, 2020 – Ipratropium bromide replaces:
- Airomir
- Apo-Salvent sans CFC
- Novo-Salbutamol HFA
- Salbutamol HFA
- Ventolin HFA
- Notice of alternative medication authorization, April 24, 2020 – Salbutamol sulfate replaces:
- Airomir
- Apo-Salvent sans CFC
- Novo-Salbutamol HFA
- Salbutamol HFA
- Ventolin HFA
- Notice of alternative medication authorization, April 24, 2020 – Formoterol fumarate dihydrate replaces:
- Airomir
- Apo-Salvent sans CFC
- Novo-Salbutamol HFA
- Salbutamol HFA
- Ventolin HFA
- Notice of alternative medication authorization, April 24, 2020 – Formoterol fumarate dihydrate replaces:
- Airomir
- Apo-Salvent sans CFC
- Novo-Salbutamol HFA
- Salbutamol HFA
- Ventolin HFA
- Notice of alternative medication authorization, April 24, 2020 – Formoterol fumarate dihydrate replaces:
- Airomir
- Apo-Salvent sans CFC
- Novo-Salbutamol HFA
- Salbutamol HFA
- Ventolin HFA
- Notice of alternative medication authorization, April 24, 2020 – Formoterol fumarate dihydrate replaces:
- Airomir
- Apo-Salvent sans CFC
- Novo-Salbutamol HFA
- Salbutamol HFA
- Ventolin HFA
- Notice of alternative medication authorization, April 22, 2020 – Bromocriptin mesylate replaces Bromocriptine
- Notice of alternative medication authorization, April 22, 2020 – Bromocriptin mesylate replaces Bromocriptine
- Notice of alternative medication authorization, April 10, 2020 – mometason furoate replaces Asmanex Twisthalerl
- Notice of alternative medication authorization, April 1, 2020 – nystatine remplace :
- Jamp-Nystatin
- pms-Nystatin
- ratio-Nystatin
- Notice of alternative medication authorization, March 23, 2020 – Timolol maleate replaces Sandoz Timolol
- Notice of alternative medication authorization, March 6, 2020 – ethambutol hydrochloride 100 mg replaces Etibi 100 mg
- Notice of alternative medication authorization, March 6, 2020 – ethambutol hydrochloride 400 mg replaces Etibi 400 mg
- Notice of alternative medication authorization, March 4, 2020 – Propylthiouracil 25 mg replaces Propyl-Thyracil 50 mg
- Notice of alternative medication authorization, March 4, 2020 – Propylthiouracil 50 mg replaces Propyl-Thyracil 50 mg
- Notice of alternative medication authorization, March 4, 2020 – Propylthiouracil 100 mg replaces Propyl-Thyracil 100 mg
- Notice of alternative medication authorization, February 26, 2020 – Prednisolone acetate replaces:
- ratio-Prednisolone
- Sandoz Prednisolone
- Notice of alternative medication authorization, January 31, 2020 – Telmisartan replaces:
- Act Telmisartan
- Apo-Telmisartan
- Auro-Telmisartan
- Micardis
- pms-Telmisartan
- Sandoz Telmisartan
- Telmisartan
- Telmisartan
- Telmisartan
- Telmisartan
- Telmisartan
- Teva-Telmisartan
- VAN-Telmisartan
- Notice of alternative medication authorization, January 31, 2020 – Telmisartan 80 mg remplace :
- Act Telmisartan
- Apo-Telmisartan
- Auro-Telmisartan
- Micardis
- pms-Telmisartan
- Sandoz Telmisartan
- Telmisartan
- Telmisartan
- Telmisartan
- Telmisartan
- Telmisartan
- Teva-Telmisartan
- VAN-Telmisartan
- Notice of alternative medication authorization, January 21, 2020 – Timolol maleate replaces:
- Apo-Timop
- Jamp-Timolol
- pms-Timolol
- Sandoz Timolol
- Timoptic
- Notice of alternative medication authorization, January 21, 2020 – Betamethasone valerate replaces:
- Betaderm
- Celestoderm V
- Notice of alternative medication authorization, January 21, 2020 – Timolol maleate replaces:
- Apo-Timop
- Jamp-Timolol
- pms-Timolol
- Sandoz Timolol
- Timoptic
- Notice of alternative medication authorization, January 20, 2020 – Timolol maleate replaces:
- Apo-Timop
- Jamp-Timolol
- pms-Timolol
- Sandoz Timolol
- Timoptic
- Notice of alternative medication authorization, January 20, 2020 – Timolol maleate replaces:
- Apo-Timop
- Jamp-Timolol
- pms-Timolol
- Sandoz Timolol
- Timoptic
- Notice of alternative medication authorization, January 13, 2020 – Heparin sodium replaces Heparine
- Notice of alternative medication authorization, January 3, 2020 – Olmesartan medoxomil replaces:
- Act Olmesartan
- Apo-Olmesartan
- Auro-Olmesartan
- GLN-Olmesartan
- Jamp-Olmesartan
- Olmesartan
- Olmetec
- pms-Olmesartan
- Riva-Olmesartan
- Sandoz Olmesartan
- Notice of alternative medication authorization, December 16, 2019 – Moclobemide 150 mg replaces Manerix 150 mg
- Notice of alternative medication authorization, December 4, 2019 – Sucralfate replaces:
- Novo-Sucralate
- Sulcrate
- Notice of alternative medication authorization, November 27, 2019 – Thiamine hydrochloride replaces:
- Thiamiject
- Thiamine
- Notice of alternative medication authorization, November 14, 2019 – Famotidine 10 et 20 mg replaces:
- Apo-Famotidine
- Famotidine
- Novo-Famotidine
- Notice of alternative medication authorization, November 14, 2019 – Famotidine 40 mg replaces:
- Apo-Famotidine
- Famotidine
- Teva-Famotidine
- Notice of alternative medication authorization, November 13, 2019 – Progesterone replaces ACT Progesterone Injection
- Notice of alternative medication authorization, November 8, 2019 – Tamoxifen citrate replaces:
- Apo-Tamox
- Novo-Tamoxifen
- Notice of alternative medication authorization, November 5, 2019 – Olmésartan médoxomil remplaces:
- Act Olmesartan
- Apo-Olmesartan
- Auro-Olmesartan
- GLN-Olmesartan
- Jamp-Olmesartan
- Olmesartan
- Olmetec
- pms-Olmesartan
- Riva-Olmesartan
- Sandoz Olmesartan
- Notice of alternative medication authorization, October 23, 2019 – Ranitidine hydrochloride replaces:
- ACT Ranitidine
- Apo-Ranitidine
- Jamp-Ranitidine
- Mar-Ranitidine
- M-Ranitidine
- pms-Ranitidine
- Ranitidine
- Ranitidine
- Ranitidine-300
- Ran-Ranitidine
- ratio-Ranitidine
- Riva-Ranitidine
- Sandoz Ranitidine
- Notice of alternative medication authorization, October 17, 2019 – Ranitidine hydrochloride replaces Teva-Ranitidine Solution
- Notice of alternative medication authorization, October 16, 2019 – amoxifen citrate 10 mg replaces:
- Apo-Tamox
- Novo-Tamoxifen
- Notice of alternative medication authorization, October 16, 2019 – Tamoxifen citrate 20 mg replaces:
- Apo-Tamox
- Nolvadez-D
- Novo-Tamoxifen
- Notice of alternative medication authorization, October 15, 2019 – Ranitidine hydrochloride replaces:
- ACT Ranitidine
- Apo-Ranitidine
- Jamp-Ranitidine
- Mar-Ranitidine
- M-Ranitidine
- pms-Ranitidine
- Ranitidine
- Ranitidine
- Ranitidine-150
- Ran-Ranitidine
- ratio-Ranitidine
- Riva-Ranitidine
- Sandoz Ranitidine
- Notice of alternative medication authorization, October 15, 2019 – Ranitidine hydrochloride 150 mg replaces:
- ACT Ranitidine
- Apo-Ranitidine
- Jamp-Ranitidine
- Mar-Ranitidine
- M-Ranitidine
- pms-Ranitidine
- Ranitidine
- Ranitidine
- Ranitidine-150
- Ran-Ranitidine
- ratio-Ranitidine
- Riva-Ranitidine
- Sandoz Ranitidine
- Notice of alternative medication authorization, October 2, 2019 – Minocycline hydrochloride replaces:
- Minocycline-50
- Mylan-Minocycline
- Novo-Minocycline
- pms-Minocycline
- Notice of alternative medication authorization, October 2, 2019 – Minocycline hydrochloride 100 mg replaces:
- Minocycline-100
- Mylan-Minocycline
- Novo-Minocycline
- pms-Minocycline
- Notice of alternative medication authorization, September 26, 2019 – Losartan potassium replaces:
- Apo-Losartan
- Auro-Losartan
- Bio-Losartan
- Co-Losartan
- Cozaar
- Jamp-Losartan
- Losartan
- Losartan
- Losartan
- Mar-Losartan
- Mint-Losartan
- pms-Losartan
- Ran-Losartan
- Sandoz Losartan
- Septa-Losartan
- Teva Losartan
- VAN-Losartan
- Notice of alternative medication authorization, September 18, 2019 – Trifluoperazine hydrochloride 1 mg replaces Trifluoperazine 1 mg.
- Notice of alternative medication authorization, September 16, 2019 – Losartan potassium 25 mg replaces:
- Apo-Losartan
- Auro-Losartan
- Bio-Losartan
- Co-Losartan
- Cozaar
- Jamp-Losartan
- Losartan
- Losartan
- Losartan
- Mar-Losartan
- Mint-Losartan
- pms-Losartan
- Ran-Losartan
- Sandoz Losartan
- Septa-Losartan
- Teva Losartan
- VAN-Losartan
- Notice of alternative medication authorization, September 16, 2019 – Losartan potassium 50 mg replaces:
- Apo-Losartan
- Auro-Losartan
- Bio-Losartan
- Co-Losartan
- Cozaar
- Jamp-Losartan
- Losartan
- Losartan
- Losartan
- Mar-Losartan
- Mint-Losartan
- pms-Losartan
- Ran-Losartan
- Sandoz Losartan
- Septa-Losartan
- Teva Losartan
- VAN-Losartan
- Notice of alternative medication authorization, September 16, 2019 – Losartan potassium 100 mg replaces:
- Apo-Losartan
- Auro-Losartan
- Bio-Losartan
- Co-Losartan
- Cozaar
- Jamp-Losartan
- Losartan
- Losartan
- Losartan
- Mar-Losartan
- Mint-Losartan
- pms-Losartan
- Ran-Losartan
- Sandoz Losartan
- Septa-Losartan
- Teva Losartan
- VAN-Losartan
- Notice of alternative medication authorization, September 6, 2019 – Clotrimazole replaces Clotrimaderm 50 g
- Notice of alternative medication authorization, August 22, 2019 – Nifedipine replaces Nifedipine
- Notice of alternative medication authorization, August 21, 2019 – Clotrimazole replaces Clotrimaderm 25 g
- Notice of alternative medication authorization, July 25, 2019 – Diazepam replaces Diastat
- Notice of alternative medication authorization, July 19, 2019 – Epinephrine replaces:
- Allerject
- EpiPen
- Notice of alternative medication authorization, July 12, 2019 – Ibuprofen 200 mg replaces:
- Apo-Ibuprofen
- Tablets of ibuprofen
- Jamp-Ibuprofene
- Notice of alternative medication authorization, July 12, 2019 – Ibuprofen 400 mg remplaces:
- Ibuprofen
- Jamp-Ibuprofene
- Novo-Profen
- Notice of alternative medication authorization, June 25, 2019 – Rifampin replaces:
- Rifadin
- Rofact 300
- Notice of alternative medication authorization, June 25, 2019 – Rifampin replaces:
- Rifadin
- Rofact 150
- Notice of alternative medication authorization, June 19, 2019 – Hydroxyzine hydrochloride replaces:
- Atarax
- pms-hydroxyzine
- Notice of alternative medication authorization, June 18, 2019 – Ibuprofen replaces Europrofen
- Notice of alternative medication authorization, June 17, 2019 – Trifluridine replaces Viroptic
- Notice of alternative medication authorization, May 29, 2019 – Metoprolol tartrate replaces:
- Lopresor SR 200 mg
- Sandoz Metoprolol SR 200
- Notice of alternative medication authorization, May 28, 2019 – Acarbose 75 mg replaces Glucobay
- Notice of alternative medication authorization, May 28, 2019 – Acarbose 50 mg replaces Glucobay
- Notice of alternative medication authorization, May 28, 2019 – Acarbose 25 mg replaces Glucobay
- Notice of alternative medication authorization, May 13, 2019 – Fludrocortisone acetate 0.05 mg replaces Florinef
- Notice of alternative medication authorization, May 13, 2019 – Fludrocortisone acetate 0.1 mg replaces Florinef
- Notice of alternative medication authorization, April 19, 2019 – Carbamazepine replaces:
- Taro-Carbamazepine
- Tégrétol
- Teva-Carbamazepine
- Notice of alternative medication authorization, March 4, 2019 – Fluvastatine sodium replaces Teva Fluvastatin
- Notice of alternative medication authorization, February 21, 2019 – Chloroquine phosphate replaces Novo-Chloroquine
- Notice of alternative medication authorization, February 1, 2019 – Prazosin hydrochloride replaces Novo-Prazin (1 mg).
- Notice of alternative medication authorization, February 1, 2019 – Prazosin hydrochloride replaces Novo-Prazin (2 mg)
- Notice of alternative medication authorization, January 30, 2019 – Tacrolimus replaces Protopic
- Notice of alternative medication authorization, January 22, 2019 – Tacrolimus replaces Protopic
- Notice of alternative medication authorization, January 18, 2019 – Imiquimod replaces:
- Aldara P
- Apo-Imiquimod
- Notice of alternative medication authorization, January 4, 2019 – Bromazepam replaces Bromazepam-3
- Notice of alternative medication authorization, December 27, 2018 – Liothyronine sodium replaces Cytomel
- Notice of alternative medication authorization, December 27, 2018 – Clobazam replaces:
- Apo-Clobazam
- Frisium
- Notice of alternative medication authorization, December 20, 2018 – Sulfasalazine replaces pms-Sulfasalazine-E. C.
- Notice of alternative medication authorization, December 3, 2018 – Mupirocine replaces Bactroban
- Notice of alternative medication authorization, December 3, 2018
- Bromazepam-6, USP (02220539)
- Notice of alternative medication authorization, November 15, 2018 – Potassium chloride replaces pms-Potassium Chloride
- Notice of alternative medication authorization, November 5, 2018
- Cytomel, USP (01919458)
- Notice of alternative medication authorization, November 5, 2018
- Act Valsartan (02337487)
- Apo-Valsartan (02371510)
- Auro-Valsartan (02414201)
- Diovan (02270528)
- Mylan-Valsartan (02383527)
- pms-Valsartan (02312999)
- Ran-Valsartan (02363062)
- Riva-Valsartan (02425440)
- Sandoz Valsartan (02356740)
- Teva Valsartan (02356643)
- Valsartan (02367726)
- Valsartan (02366940)
- Valsartan (02384523)
- Act Valsartan (02337495)
- Apo-Valsartan (02371529)
- Auro-Valsartan (02414228)
- Diovan (02244781)
- Mylan-Valsartan (02383535)
- pms-Valsartan (02313006)
- Ran-Valsartan (02363100)
- Riva-Valsartan (02425459)
- Sandoz Valsartan (02356759)
- Teva Valsartan (02356651)
- Valsartan (02367734)
- Valsartan (02366959)
- Valsartan (02384531)
- Notice of alternative medication authorization, November 1, 2018
- Novo-Chloroquine, USP (00021261)
- Notice of alternative medication authorization, October 30, 2018
- Novo-Ranidine, USP (02242940)
- Notice of alternative medication authorization, October 15, 2018
- Act Pramipexole, USP (02297302)
- Apo-Pramipexole, USP (02292378)
- Auro-Pramipexole, USP (02424061)
- Mirapex, USP (02237145)
- pms-Pramipexole, USP (02290111)
- Pramipexole, USP (02325802)
- Pramipexole, USP (02367602)
- Pramipexole, USP (02309122)
- Sandoz Pramipexole, USP (02315262)
- Teva-Pramipexole, USP (02269309)
- Act Pramipexole, USP (02297310)
- Apo-Pramipexole, USP (02292386)
- Auro-Pramipexole, USP (02424088)
- pms-Pramipexole, USP (02290138)
- Pramipexole, USP (02325810)
- Pramipexole, USP (02367610)
- Pramipexole, USP (02309130)
- Sandoz Pramipexole, USP (02315270)
- Teva-Pramipexole, USP (02269317)
- Act Pramipexole, USP (02297329)
- Apo-Pramipexole, USP (02292394)
- Auro-Pramipexole, USP (02424096)
- pms-Pramipexole, USP (02290146)
- Pramipexole, USP (02325829)
- Pramipexole, USP (02367629)
- Pramipexole, USP (02309149)
- Sandoz Pramipexole, USP (02315289)
- Teva-Pramipexole, USP (02269325)
- Notice of alternative medication authorization, October 5, 2018
- Nifedipine, USP (00725110)
- Notice of alternative medication authorization, September 28, 2018
- Act Pramipexole, USP (02297302)
- Apo-Pramipexole, USP (02292378)
- Auro-Pramipexole, USP (02424061)
- Mirapex, USP (02237145)
- pms-Pramipexole, USP (02290111)
- Pramipexole, USP (02325802)
- Pramipexole, USP (02367602)
- Pramipexole, USP (02309122)
- Sandoz Pramipexole, USP (02315262)
- Teva-Pramipexole, USP (02269309)
- Act Pramipexole, USP (02291310)
- Apo-Pramipexole, USP (02292386)
- Auro-Pramipexole, USP (02424088)
- pms-Pramipexole, USP (02290138)
- Pramipexole, USP (02325810)
- Pramipexole, USP (02367610)
- Pramipexole, USP (02309130)
- Sandoz Pramipexole, USP (02315270)
- Teva-Pramipexole, USP (02269317)
- Act-Pramipexole, USP (02297329)
- Apo-Pramipexole, USP (02292394)
- Auro-Pramipexole, USP (02424096)
- pms-Pramipexole, USP (02290146)
- Pramipexole, USP (02325829)
- Pramipexole, USP (02367629)
- Pramipexole, USP (02309149)
- Sandoz Pramipexole, USP (02315289)
- Teva-Pramipexole, USP (02269325)
- Notice of alternative medication authorization, September 17, 2018
- Act Pramipexole, USP (02297302)
- Apo-Pramipexole, USP (02292378)
- Auro-Pramipexole, USP (02424061)
- Mirapex, USP (02237145)
- pms-Pramipexole, USP (02290111)
- Pramipexole, USP (02325802)
- Pramipexole, USP (02367602)
- Pramipexole, USP (02309122)
- Sandoz Pramipexole, USP (02315262)
- Teva-Pramipexole, USP (02269309)
- Act Pramipexole, USP (02297310)
- Apo-Pramipexole, USP (02292386)
- Auro-Pramipexole, USP (02424088)
- pms-Pramipexole, USP (02290138)
- Pramipexole, USP (02325810)
- Pramipexole, USP (02367610)
- Pramipexole, USP (02309130)
- Sandoz Pramipexole, USP (02315270)
- Teva-Pramipexole, USP (02269317)
- Act Pramipexole, USP (02297329)
- Apo-Pramipexole, USP (02292394)
- Auro-Pramipexole, USP (02424096)
- pms-Pramipexole, USP (02290146)
- Pramipexole, USP (02325829)
- Pramipexole, USP (02367629)
- Pramipexole, USP (02309149)
- Sandoz Pramipexole, USP (02315289)
- Teva-Pramipexole, USP (02269325)
- Notice of alternative medication authorization, September 4, 2018
- Allerject, USP (02382059)
- EpiPen Jr. USP (00578657)
- Notice of alternative medication authorization, September 4, 2018
- Allerject, USP (02382067)
- EpiPen, USP (00509558)
- Notice of alternative medication authorization, September 1, 2018
- Erythromycin, USP (02326663)
Register
- List of medications, December 14, 2022
- List of medications, November 9, 2022
- List of medications, September 28, 2022
- List of medications, August 17, 2022
- Notice of correction made to the List of medications, July 6, 2022
- List of medications, July 6, 2022
- Notice of correction made to the List of medications, May 26, 2022
- List of medications, May 26, 2022
- List of medications, April 13, 2022
- List of medications, March 2, 2022
- List of medications, Februrary 2, 2022
- List of medications, December 15, 2021
- List of medications, November 10, 2021
- Notice of correction made to the List of medications, September 29, 2021
- List of medications, September 29, 2021
- List of medications, August 18, 2021
- List of medications, July 7, 2021
- List of medications, May 27, 2021
- List of medications, April 14, 2021
- List of medications, March 3, 2021
- List of medications, February 3, 2021
- List of medications, December 16, 2020
- List of medications, November 11, 2020
- Notice of correction made to the List of medications, September 30, 2020
- List of medications, September 30, 2020
- List of medications, August 19, 2020
- List of medications, July 8, 2020
- Notice of correction made to the list of medications, May 27, 2020
- List of medications, May 27, 2020
- Notice of correction made to the List of medications, April 29, 2020
- List of medications, April 29, 2020
- List of medications, March 4, 2020
- List of medications, February 5, 2020
- List of medications, December 18, 2019
- List of medications, November 14, 2019
- List of medications, October 2, 2019
- List of medications, August 15, 2019
- List of medications, July 10, 2019
- List of medications, May 23, 2019
- List of medications, April 11, 2019
- List of medications, March 7, 2019
- List of medications, February 1, 2019